Acrux Ltd (ACR)

Sydney
0.125
0.000(0.00%)
  • Volume:
    1,000
  • Bid/Ask:
    0.125/0.130
  • Day's Range:
    0.125 - 0.125

ACR Overview

Prev. Close
0.13
Day's Range
0.125-0.125
Revenue
4.17M
Open
0.125
52 wk Range
0.115-0.32
EPS
-0.06
Volume
1,000
Market Cap
26.37M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
291,686
P/E Ratio
-
Beta
1.15
1-Year Change
-19.35%
Shares Outstanding
210,993,671
Next Earnings Date
25 Aug 2021
What is your sentiment on Acrux Ltd?
or
Vote to see community's results!

Acrux Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Acrux Ltd Company Profile

Acrux Ltd Company Profile

Employees
0
Market
Australia

Acrux Limited, together with its subsidiaries, develops and commercializes generic and specialty topical pharmaceuticals in Australia, Germany, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. Acrux Limited was founded in 1998 and is based in West Melbourne, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.